N

National Institute of Allergy and Infectious Diseases (NIAID)

1196 employees

National Institute of Allergy and Infectious is a medical research agency that supports basic and applied research for allergic diseases.

Investor insights

Sectors invested in

Biotechnology61
Health Care34
Medical10
Life Science9
Biopharma8
Therapeutics8
Medical Device7
Pharmaceutical7
Health Diagnostics7
Genetics6
Clinical Trials5
Genomics5
Diagnostics5
Research4
Bioinformatics4
Manufacturing3
Infectious Diseases3
genome3
Plasmids3
Hi-C3

Funding rounds participated in

$2M sweet spot round size

Most of their 74 investments are in rounds between $600K and $4.3M

Investor type

Government Office

Basic info

Industry

government administration

Sectors

Biotechnology
Association
Health Care
Non Profit
Education

Date founded

1887

Investments made

R

ResVita Bio raised $250K on September 18, 2023

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

E

Exavir Therapeutics raised $3M on August 22, 2023

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

P

PRIMETIME LIFE SCIENCES, LLC raised undisclosed on August 17, 2023

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

T

TFF Pharmaceuticals, Inc. raised $3M on June 26, 2023

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

T

Truly Technologies LLC raised $273K on May 1, 2023

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

B

BARUCH S. BLUMBERG INSTITUTE raised $5.5M on November 21, 2022

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

M

Microbiotix, Inc raised $2.1M on November 21, 2022

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

T

The Duke Human Vaccine Institute raised $26M on October 11, 2022

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

O

Omniose raised $3.6M on October 11, 2022

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

K

Kovina Therapeutics raised $300K on September 12, 2022

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

FAQ